TRAW - Traws Pharma Inc Year-over-year net earnings per share growth for the last 12 months

Public company logo of trawspharma.com (TRAW)

Traws Pharma, Inc. (TRAW) is developing innovative oral antivirals, asserting pricing power through its patent portfolio. The startup is currently scaling its portfolio of small-molecule therapies to combat respiratory infections. Quarterly EPS variation reflects profit dynamics, where the -22.50 level represents the current value. Share growth is supported by successful clinical trials against influenza and COVID, as well as the prospects of licensing its developments to corporate behemoths.

Traws Pharma Inc (TRAW) Year-over-year net earnings per share change for the last twelve months: for the period 04/04/2024 - 11/16/2026

trawspharma.com (TRAW) - metric breakdowns and financial figures

- market value and analyst target forecast:
- market capitalization statistics:
Initial company analysis:trawspharma.com, TRAW
Manufactured product of Traws Pharma, Inc.

To objectively assess the operational efficiency of Traws Pharma, Inc. (TRAW), investors must track net profit dynamics converted into per-share value. By analyzing the growth rate of quarterly earnings per share, you can observe a smoothed daily yield curve that will eventually reflect the success of antiviral drug commercialization and the long-term market launch of respiratory infection therapies.

Main competitors

Gilead Sciences Inc (GILD) - Year-over-year earnings per share growth for the last twelve months|Cidara - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NVAX|Quarterly EPS earnings growth curevac.com|Year-over-year earnings per share growth for the last twelve months Valneva Corp (VALN)|Year-over-year earnings per share growth for the last twelve months VIR (Vir Biotechnology)|Year-over-year earnings per share growth for the last twelve months TPOXX SIGA|EBS - Year-over-year net earnings per share growth for the last 12 months|AVIR: Year-over-year net earnings per share growth for the last 12 months|IVVD (Invivyd Inc) - Year-over-year earnings per share growth for the last 12 months|ENTA: Quarterly EPS earnings growth|INO (Inovio) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months HilleVax Corp|Quarterly EPS earnings growth Kalaris Tx|Quarterly EPS earnings growth DYAI|Year-over-year earnings per share growth for the last twelve months NNVC (NanoViricides)|Quarterly EPS earnings growth TLPH (Talphera Corporation)|Year-over-year net earnings per share change for the last twelve months Cocrystal (COCP)|Dogwood Therapeutics Inc. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Qualigen Corp|ALVR (AlloVir Bio) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months VBI Vaccines, Inc.|VIRI (virios.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months VXRT (Vaxart, Inc.)